Literature DB >> 758155

Disease caused by a marine Vibrio. Clinical characteristics and epidemiology.

P A Blake, M H Merson, R E Weaver, D G Hollis, P C Heublein.   

Abstract

We studied the clinical characteristics and epidemiology of disease associated with a rare, unnamed halophilic lactose-fermenting Vibrio species in 39 persons from whom the organism had been isolated. Two distinct clinical presentations were seen. In the first, the illness began with septicemia, often within 24 hours after raw oysters had been eaten; 18 of 24 such patients had pre-existing hepatic disease, and 11 of the 24 died. In the second, there was a wound infection after exposure to seawater or an injury incurred during the handling of crabs; none of these persons had pre-existing hepatic disease, and one of 15 died. Most cases (85 per cent) occurred during relatively warm months (May to October) in men (90 per cent) 40 or more years of age (95 per cent). This Vibrio species is a pathogen and should be considered in the differential diagnosis of septicemia with secondary skin lesions and of wound infections after exposure to seawater.

Entities:  

Mesh:

Year:  1979        PMID: 758155     DOI: 10.1056/NEJM197901043000101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  170 in total

1.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

3.  Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus.

Authors:  G N Stelma; A L Reyes; J T Peeler; C H Johnson; P L Spaulding
Journal:  Appl Environ Microbiol       Date:  1992-09       Impact factor: 4.792

Review 4.  Epidemiology of seafood-associated infections in the United States.

Authors:  Martha Iwamoto; Tracy Ayers; Barbara E Mahon; David L Swerdlow
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Temporal and spatial variability in the distribution of Vibrio vulnificus in the Chesapeake Bay: a hindcast study.

Authors:  Vinita Banakar; Guillaume Constantin de Magny; John Jacobs; Raghu Murtugudde; Anwar Huq; Robert J Wood; Rita R Colwell
Journal:  Ecohealth       Date:  2011-12       Impact factor: 3.184

6.  Pulmonary damage by Vibrio vulnificus cytolysin.

Authors:  J W Park; S N Ma; E S Song; C H Song; M R Chae; B H Park; R W Rho; S D Park; H R Kim
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Cloning and sequence analysis of a novel hemolysin gene (vllY) from Vibrio vulnificus.

Authors:  T M Chang; Y C Chuang; J H Su; M C Chang
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

8.  Cloning and characterization of vuuA, a gene encoding the Vibrio vulnificus ferric vulnibactin receptor.

Authors:  A C Webster; C M Litwin
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

9.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

10.  Rapid alterations to marine microbiota communities following an oil spill.

Authors:  Brad J Gemmell; Hernando P Bacosa; Ben O Dickey; Colbi G Gemmell; Lama R Alqasemi; Edward J Buskey
Journal:  Ecotoxicology       Date:  2018-03-19       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.